Startup Venture Entrepreneur Shares His Formula for Success
"Start. Scale. Exit. Repeat.: Serial Entrepreneurs' Secrets Revealed!" by
with Forbes Books
This release is posted on behalf of Forbes Books (operated by Advantage Media Group under license).
There's no shortage of media reporting that explores why startup companies fail—but what do those who succeed have in common? In his new book, Start. Scale. Exit. Repeat.,
From his formative years on a Canadian family farm to successfully exiting companies that today are valued at more than a billion dollars, Campbell collects firsthand experiences in helping build, scale, and sell startup companies. He also shares insights from fellow serial entrepreneurs and thought leaders.
In Start. Scale. Exit. Repeat., Campbell keeps his winning formula simple, leading his readers from the initial idea to the high-value sale. He provides real-life examples, best practices, and "Golden Nuggets" of wisdom derived from both his successes and failures. Topics include vetting your idea, picking an all-star team of partners and employees, finding the right investors and funding, preparing for negotiations, and how to repeat the formula—each time better and faster.
"I don't pretend to be the next
About
Hailing from his family's farm in
About Forbes Books
Launched in 2016 in partnership with Advantage Media Group, Forbes Books is the exclusive business book publishing imprint of Forbes. Forbes Books offers business and thought leaders an innovative, speed-to-market, fee-based publishing model and a suite of services designed to strategically and tactically support authors and promote their expertise. For more information, visit books.forbes.com.
Media Contacts
Forbes Books Media Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/startup-venture-entrepreneur-shares-his-formula-for-success-301943667.html
SOURCE Forbes Books
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ZTE CDO Cui Li at MWC Shanghai 2026: Unlocking Value and Embracing Uncertainty in the AI Era
- Annual General Meeting of Jyske Realkredit A/S
- Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company into Late-Stage Clinical Development
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Bill Gates, Steve JobsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share